Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.
D000818:Animals; D000918:Antibody Specificity; D001665:Binding Sites; D002462:Cell Membrane / Q000276:immunology; D002478:Cells, Cultured; D003208:Concanavalin A / Q000008:administration & dosage / Q000494:pharmacology*; D003601:Cytotoxicity Tests, Immunologic; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D007065:Idoxuridine / Q000378:metabolism; D007111:Immunity, Cellular / Q000187:drug effects*; D007457:Iodine Radioisotopes; D007942:Leukemia, Experimental / Q000276:immunology*; D008070:Lipopolysaccharides; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D008979:Moloney murine leukemia virus / Q000276:immunology; D013154:Spleen / Q000166:cytology
D007457:Iodine Radioisotopes; D008070:Lipopolysaccharides; D003208:Concanavalin A; D007065:Idoxuridine